Cited by 87Luminescence and Fluorescent MaterialsNanoplatforms for cancer theranosticsPhotodynamic Therapy Research Studies

The Midas Touch by Iridium: A Second Near-Infrared Aggregation-Induced Emission-Active Metallo-Agent for Exceptional Phototheranostics of Breast Cancer

You, Caifa, Tian, Leyuan, Zhu, Jun, Wang, Lei, Tang, Ben Zhong, Wang, Dong·2025·Journal of the American Chemical Society

Abstract

Developing small organic molecular phototheranostic agents with second near-infrared (NIR-II) aggregation-induced emission (AIE) is paramount for the phototriggered diagnostic imaging and synchronous in situ therapy of cancer via an excellent balance of the excited states energy dissipations. In this study, a multifunctional iridium(III) complex is exploited by the coordination of an AIE-active N^N ancillary ligand with a trivalent iridium ion. The resultant complex DPTPzIr significantly outperforms its parent ligand in terms of absorption/emission wavelengths, reactive oxygen species (ROS) production, and photothermal conversion, which simultaneously endow DPTPzIr nanoparticles with matched absorption peak to commercial 808 nm laser, the longest NIR-II emission peak (above 1100 nm) among those previously reported AIE iridium(III) complexes, potentiated type-I ROS generation, and as high as 60.5% of photothermal conversion efficiency. Consequently, DPTPzIr nanoparticles perform well in multimodal image-guided photodynamic therapy-photothermal therapy for breast cancer in tumor-bearing mice, enabling precise tumor diagnosis and complete ablation with high biocompatibility. Our present work provides a simple, feasible, and effective paradigm for the development of advanced phototheranostic agents.

Integrity signals

Registry

Crossref · 10.1021/jacs.4c15150

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DSPE-mPEG2000-encapsulated DPTPzIr NPs displayed an absorption maximum at 810 nm, demonstrating excellent spectral overlap with commercially available 808 nm laser.

    “DSPE-mPEG2000-encapsulated DPTPzIr NPs displayed an absorption maximum at 810 nm, demonstrating excellent spectral overlap with commercially available 808 nm laser.”
  • DPTPzIr NPs achieved a remarkably high PCE of 60.5% and exhibited potent •OH generation capability upon laser irradiation, which was beneficial to overcoming tumor hypoxia.

    “Moreover, DPTPzIr NPs achieved a remarkably high PCE of 60.5% and exhibited potent •OH generation capability upon laser irradiation, which was beneficial to overcoming tumor hypoxia.”
  • Upon 808 nm laser irradiation, the tumor temperature was effectively elevated to 59.5 °C, resulting in complete tumor ablation through the synergistic action of PDT and PTT.

    “Upon 808 nm laser irradiation, the tumor temperature was effectively elevated to 59.5 °C, resulting in complete tumor ablation through the synergistic action of PDT and PTT.”
  • Relative to the parent ligand, DPTPzIr exhibited a significant emission red-shift to 1100 nm, accompanied by marked enhancements in ROS generation yield and PCE.

    “Relative to the parent ligand, DPTPzIr exhibited a significant emission red-shift to 1100 nm, accompanied by marked enhancements in ROS generation yield and PCE.”
  • In 4T1 tumor-bearing murine models, DPTPzIr NPs enabled NIR-II fluorescence/PA/photothermal trimodal imaging, with the signal intensity reaching its maximum 36 h post injection.

    “In 4T1 tumor-bearing murine models, DPTPzIr NPs enabled NIR-II fluorescence/PA/photothermal trimodal imaging, with the signal intensity reaching its maximum 36 h post injection.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
You, C., Tian, L., Zhu, J., Wang, L., Tang, B. Z., & Wang, D.
Affiliations
  • Shenzhen University (CN)
  • Chinese University of Hong Kong, Shenzhen (CN)
Corresponding author
Wang, Dong
Venue
Journal of the American Chemical Society
Published
2025-01-07
Volume
147
Issue
2
Pages
2010-2020
ISSN
  • 0002-7863 (ISSN-L)
  • 1520-5126
OpenAlex
W4406115797
Cited by
87
References
52
Citations by year
2026: 50 · 2025: 37
FWCI
18.27
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Chemical Society (publishedVersion)
  • PubMed (publishedVersion)
  • Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
Funders
  • Science and Technology Foundation of Shenzhen City (20220809130438001)
  • National Natural Science Foundation of China (22175120, 52122317)
  • Medical-Engineering Interdisciplinary Research Foundation of Shenzhen University (2023YG021)
  • Pearl River Talent Recruitment Program (2019QN01Y103)
  • Research Team Cultivation Program of Shenzhen University (2023QNT003)
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
Keywords
phototheranostics, aggregation-induced emission, iridium(III) complexes, breast cancer, photothermal conversion, photodynamic therapy, reactive oxygen species generation, multimodal imaging, tumor ablation
MeSH terms
Theranostic Nanomedicine, Photothermal Therapy, Animals, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Infrared Rays, Iridium, Reactive Oxygen Species, Cell Line, Tumor, Mice, Coordination Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review